Literature DB >> 19629855

Sex preference as a determinant of contraceptive use in matrilineal societies: a study on the Garo of Bangladesh.

Mohammad Amirul Islam1, M Rakibul Islam, Banya Banowary.   

Abstract

OBJECTIVES: This paper explores the presence of sex preference and its influence on contraceptive use among the Garo, a matrilineal community, of Bangladesh.
METHODS: In this study, 223 currently married Garo women were interviewed, selected purposively from two districts of Bangladesh, where most of the Garo people live. A binary logistic regression model was fitted to explore the determinants of current use of contraceptives among the Garo community.
RESULTS: About 80% of the Garo women were currently using contraceptive methods, which was much higher than the contraceptive prevalence at the national level (55.8%). However, the use of modern male methods was very low in that community. Regression analysis revealed that the strong preference for girls was a significant determinant of contraceptive use.
CONCLUSIONS: Even though the Garo apply contraception more than the Bangladeshi community in general, their strong preference for girls may restrain its success. Family planning information can be designed so as not to challenge the matrilineal structure of the society and both spouses counselled together to promote also modern male methods.

Entities:  

Mesh:

Year:  2009        PMID: 19629855     DOI: 10.1080/13625180903033460

Source DB:  PubMed          Journal:  Eur J Contracept Reprod Health Care        ISSN: 1362-5187            Impact factor:   1.848


  2 in total

1.  Daughter preference and contraceptive-use in matrilineal tribal societies in Meghalaya, India.

Authors:  Pralip Kumar Narzary; Shilpi Mishra Sharma
Journal:  J Health Popul Nutr       Date:  2013-06       Impact factor: 2.000

2.  Socioeconomic Correlates of Contraceptive Use among the Ethnic Tribal Women of Bangladesh: Does Sex Preference Matter?

Authors:  S M Mostafa Kamal; Che Hashim Hassan
Journal:  J Family Reprod Health       Date:  2013-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.